Summary & Overview
CPT 15277: Skin Substitute Application for Large or Complex Wounds
CPT code 15277 denotes the application of a skin substitute (allograft or xenograft) for coverage of wounds involving anatomically sensitive or multiple sites when the treated area is ≥100 cm2 in patients 10 and older, or 1% of body area in children under 10. This code captures complex wound management using biological dressings on areas such as the face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and multiple digits. Nationally, the code matters for consistent coding of advanced wound care and for tracking the use of skin substitutes across surgical and outpatient settings.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise benchmarking and policy-relevant context for billing and coverage of skin substitute applications, including typical sites of service and clinical scenarios that align with code descriptors. The publication outlines clinical context for use, common modifiers in payer practice patterns, and where to find related coding guidance. Data not available in the input are noted where applicable. This summary equips clinicians, billing specialists, and policy analysts with a clear understanding of when CPT code 15277 applies and what national stakeholders typically consider when assessing claims for large or complex wound skin substitute applications.
Billing Code Overview
CPT code 15277 describes the application of a skin substitute (allograft or xenograft) to cover wounds on complex or sensitive anatomical sites. The code applies when the treated area is greater than or equal to 100 cm2 in patients age 10 and older, or 1 percent of body area for children under 10.
-
Service type: Application of skin substitute grafts for large or anatomically complex wounds.
-
Typical site of service: Procedures are performed on the face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, and can occur in settings appropriate for surgical wound management such as outpatient surgery centers, hospital outpatient departments, and specialty clinics.
Clinical & Coding Specifications
Clinical Context
A 56-year-old male patient presents after a motor vehicle collision with full-thickness soft tissue loss to the left cheek and perioral region resulting in a 120 cm2 facial wound. Initial emergency care included hemostasis and wound debridement. Once the wound bed is clean and viable tissue is present, the reconstructive surgeon elects to apply a biologic skin substitute (allograft) to provide temporary coverage, promote granulation, and protect underlying structures prior to definitive reconstruction. The procedure is performed in an outpatient ambulatory surgery center with local or general anesthesia depending on patient factors. The clinical workflow includes preoperative assessment and consent, wound measurement and documentation (area ≥100 cm2), preparation of the skin substitute per manufacturer instructions, application and fixation of the graft to the facial wound, dressing application, and post-procedure wound care instructions with planned follow-up for graft assessment and subsequent definitive closure or reconstructive staged procedures.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Surgeon performed the procedure | Use when the reporting clinician is the primary surgeon who applied the skin substitute. |
22 |